U.S. Court in New York Again Rejects Safety-Net Providers' Antitrust Action Against Drug Makers over 340B Discounts
- February 09, 2024
Two safety-net providers won’t have another chance to allege that four pharmaceutical companies violated federal and state antitrust laws by coordinating to rescind long-standing discounts under the 340B program following a February 1 district court ruling rejected the proposed second amended complaint.
ARTICLE TAGS
You must be logged in to access this content.